Please login to the form below

Not currently logged in
Email:
Password:
PMLiVE Top Pharma List

43

Revenue 2017

Perjeta

The Top Pharma List's top 50 pharmaceutical products by global sales ranking is compiled from GlobalData's pharmaceutical revenue figures. Perjeta was produced by Roche.

Roche's Kadcyla fails in gastric cancer trial

Roche's Kadcyla fails in gastric cancer trial Among its best-performing products were breast cancer therapy Perjeta (pertuzumab), up 66% to CHF 1.04bn in the nine-month period, and this in turn helped boost sales of Herceptin

Roche's Perjeta launches in UK for early breast cancer

Roche's Perjeta launches in UK for early breast cancer Roche's Perjeta is now licensed for use in the UK as a treatment for early-stage breast cancer, a few weeks after the new indication was approved in Europe. ... Perjeta was already approved to treat previously-untreated advanced HER2-positive breast

European approval for Roche’s next-gen breast cancer drug

European approval for Roche’s next-gen breast cancer drug Perjeta now available in EU for use before surgery in early stage aggressive breast cancer.  . ... We are committed to making the Perjeta regimen available to appropriate patients in the EU as early as possible.”.

UK pharma rebate payment doubles in one year

UK pharma rebate payment doubles in one year First quarter repayment £138m higher than this time last year

Roche maintains dominance as leading cancer drugmaker

Roche maintains dominance as leading cancer drugmaker drugs such as its next-generation breast cancer drug Perjeta (pertuzumab). ... This was highlighted in England where last year the country's health technology assessor NICE said Perjeta was nearly double the price (at £90, 000) than it would consider

[ Previous 5 results ] 2 3 4 5 6 7 8 9 10 11 [ Next 5 results ]

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Anthill Agency

Digital communications agency empowering clients through their digital transformation journey. Whether through training, delivering solutions or devising digital strategies, we...

Latest intelligence

The importance of co-creation with patients
Overcoming the barriers...
Three billboards on the road to multichannel
Chris Ross examines the trends driving multichannel communication in 2019...
How Medisafe is using AI to improve patient adherence
Dina Patel speaks to Omri Shor, Co-Founder and CEO of Medisafe, to find out how his medication management app is tackling the problem of poor adherence....

Infographics